FCRL3 gene polymorphisms contribute to the radiographic severity rather than susceptibility of rheumatoid arthritis

Human Immunology

Volumn 73, Issue 5, 2012, Pages 537-542

  Han, Seung Woo ^a   Sa, Keum Hee ^b   Kim, Sung Il ^c   Lee, Sang Il ^d   Park, Yong Wook ^e   Lee, Shin Seok ^e   Yoo, Wan Hee ^f   Kang, Jin Young ^b   Soe, Jae Seok ^b   Nam, Eon Jeong ^b   Lee, Jongmin ^b   Park, Jae Yong ^b   Kang, Young Mo ^b  

^a Daegu Fatima Hospital   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

^d Gyeongsang National University School of Medicine   (South Korea)

^e Chonnam National University Medical School   (South Korea)

^f Chonbuk National University   (South Korea)

Author keywords

FCRL3; Polymorphism; Radiographic severity; Rheumatoid arthritis; Susceptibility

Indexed keywords

FC RECEPTOR; FC RECEPTOR LIKE 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; INTRON; JOINT RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; CASE-CONTROL STUDIES; DNA FINGERPRINTING; FEMALE; GENETIC HETEROGENEITY; HAPLOTYPES; HUMANS; INTRONS; JOINTS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, IMMUNOLOGIC; SEQUENCE ANALYSIS, DNA; SEVERITY OF ILLNESS INDEX;

EID: 84862801520     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.02.011     Document Type: Article

References (44)

1. Weyand C.M., Kang Y.M., Kurtin P.J., Goronzy J.J. The power of the third dimension: tissue architecture and autoimmunity in rheumatoid arthritis. Curr Opin Rheumatol 2003, 15:259-266.
2. Tang Q., Bluestone J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008, 9:239-244.
3. Bouaziz J.D., Yanaba K., Tedder T.F. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 2008, 224:201-214.
4. Davis R.S., Dennis G., Odom M.R., Gibson A.W., Kimberly R.P., Burrows P.D., et al. Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family. Immunol Rev 2002, 190:123-136.
5. Kochi Y., Yamada R., Suzuki A., Harley J.B., Shirasawa S., Sawada T., et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005, 37:478-485.
6. Ikari K., Momohara S., Nakamura T., Hara M., Yamanaka H., Tomatsu T., et al. Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann Rheum Dis 2006, 65:671-673.
7. Davis R.S., Wang Y.H., Kubagawa H., Cooper M.D. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci U S A 2001, 98:9772-9777.
8. Hatzivassiliou G., Miller I., Takizawa J., Palanisamy N., Rao P.H., Iida S., et al. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 2001, 14:277-289.
9. Miller I., Hatzivassiliou G., Cattoretti G., Mendelsohn C., Dalla-Favera R. IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells. Blood 2002, 99:2662-2669.
10. Nagata S., Ise T., Pastan I. Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells. J Immunol 2009, 182:7518-7526.
11. Swainson L.A., Mold J.E., Bajpai U.D., McCune J.M. Expression of the autoimmune susceptibility gene FCRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. J Immunol 2010, 184:3639-3647.
12. Davis R.S., Ehrhardt G.R., Leu C.M., Hirano M., Cooper M.D. An extended family of Fc receptor relatives. Eur J Immunol 2005, 35:674-680.
13. Wu H., Yang L.H., Zuo J., Liang Y.L., Li P.Q., Liu W., et al. Fc receptor-like 3 gene polymorphisms confer susceptibility to rheumatoid arthritis in a Chinese population. Hum Immunol 2010, 71:1203-1208.
14. Begovich A.B., Chang M., Schrodi S.J. Meta-analysis evidence of a differential risk of the FCRL3 -169T→C polymorphism in white and East Asian rheumatoid arthritis patients. Arthritis Rheum 2007, 56:3168-3171.
15. Choi C.B., Kang C.P., Seong S.S., Bae S.C., Kang C. The -169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case-control study of Koreans. Arthritis Rheum 2006, 54:3838-3841.
16. Eyre S., Bowes J., Potter C., Worthington J., Barton A. Association of the FCRL3 gene with rheumatoid arthritis: a further example of population specificity?. Arthritis Res Ther 2006, 8:R117.
17. Hu X., Chang M., Saiki R.K., Cargill M.A., Begovich A.B., Ardlie K.G., et al. The functional -169T→C single-nucleotide polymorphism in FCRL3 is not associated with rheumatoid arthritis in white North Americans. Arthritis Rheum 2006, 54:1022-1025.
18. Martínez A., Sánchez E., Valdivia A., Orozco G., López-Nevot M.A., Pascual-Salcedo D., et al. Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis. Ann Rheum Dis 2006, 65:1188-1191.
19. Newman W.G., Zhang Q., Liu X., Walker E., Ternan H., Owen J., et al. Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis Rheum 2006, 54:3820-3827.
20. Takata Y., Inoue H., Sato A., Tsugawa K., Miyatake K., Hamada D., et al. Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies. J Hum Genet 2008, 53:163-173.
21. Thabet M.M., Wesoly J., Slagboom P.E., Toes R.E., Huizinga T.W. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis 2007, 66:803-806.
22. Plant D., Barton A., Thomson W., Ke X., Eyre S., Hinks A., et al. A re-evaluation of three putative functional single nucleotide polymorphisms in rheumatoid arthritis. Ann Rheum Dis 2009, 68:1373-1375.
23. Owen C.J., Kelly H., Eden J.A., Merriman M.E., Pearce S.H., Merriman T.R. Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab 2007, 92:1106-1111.
24. Eike M.C., Nordang G.B., Karlsen T.H., Boberg K.M. The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases. Ann Rheum Dis 2008, 67:1287-1291. Vatn MH, IBSEN study group.
25. Kochi Y., Myouzen K., Yamada R., Suzuki A., Kurosaki T., Nakamura Y., et al. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J Immunol 2009, 183:5502-5510.
26. Bongi S.M., Manetti R., Melchiorre D., Turchini S., Boccaccini P., Vanni L., et al. Anti-cyclic citrullinated peptide antibodies are highly associated with severe bone lesions in rheumatoid arthritis anti-CCP and bone damage in RA. Autoimmunity 2004, 37:495-501.
27. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
28. Sharp J.T., Young D.Y., Bluhm G.B., Brook A., Brower A.C., Corbett M., et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?. Arthritis Rheum 1985, 28:1326-1335.
29. Excoffier L., Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995, 12:921-927.
30. Excoffier L., Laval G., Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 2005, 1:47-50.
31. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
32. Lee Y.H., Woo J.H., Choi S.J., Ji J.D., Song G.G. Fc receptor-like 3 -169 C/T polymorphism and RA susceptibility: a meta-analysis. Rheumatol Int 2010, 30:947-953.
33. Chen J.Y., Wang C.M., Wu Y.J., Kuo S.N., Shiu C.F., Chang S.W., et al. Disease phenotypes and gender association of FCRL3 single-nucleotide polymorphism -169T/C in Taiwanese patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 2011, 38:264-270.
34. Maehlen M.T., Nordang G.B., Syversen S.W., van der Heijde D.M., Kvien T.K., Uhlig T., et al. FCRL3 -169C/C genotype is associated with anti-citrullinated protein antibody-positive rheumatoid arthritis and with radiographic progression. J Rheumatol 2011, 38:2329-2335.
35. Won W.J., Foote J.B., Odom M.R., Pan J., Kearney J.F., Davis R.S. Fc receptor homolog 3 is a novel immunoregulatory marker of marginal zone and B1 B cells. J Immunol 2006, 177:6815-6823.
36. Sokka T.M., Kaarela K., Möttönen T.T., Hannonen P.J. Conventional monotherapy compared to a "sawtooth" treatment strategy in the radiographic progression of rheumatoid arthritis over the first eight years. Clin Exp Rheumatol 1999, 17:527-532.
37. Pincus T., O'Dell J.R., Kremer J.M. Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy. Ann Intern Med 1999, 131:768-774.
38. Coenen M.J., Gregersen P.K. Rheumatoid arthritis: a view of the current genetic landscape. Genes Immun 2009, 10:101-111.
39. Ioannidis J.P., Trikalinos T.A., Ntzani E.E., Contopoulos-Ioannidis D.G. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003, 361:567-571.
40. Hirschhorn J.N., Lohmueller K., Byrne E., Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002, 4:45-61.
41. Hoffmann S.C., Stanley E.M., Cox E.D., DiMercurio B.S., Koziol D.E., Harlan D.M., et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002, 2:560-567.
42. Pearce S.H., Merriman T.R. Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med 2006, 12:90-98.
43. Devlin B., Roeder K. Genomic control for association studies. Biometrics 1999, 55:997-1004.
44. Barton A., Bowes J., Eyre S., Symmons D., Worthington J., Silman A. Investigation of polymorphisms in the PADI4 gene in determining severity of inflammatory polyarthritis. Ann Rheum Dis 2005, 64:1311-1315.